COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
3.040
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
3.209
+0.169 (5.56%)
After-hours: Mar 28, 2025, 6:30 PM EDT
COSCIENS Biopharma Employees
COSCIENS Biopharma had 12 employees as of December 31, 2020. The number of employees decreased by 44 or -78.57% compared to the previous year.
Employees
12
Change
-44
Growth
-78.57%
Revenue / Employee
$402,833
Profits / Employee
-$1,934,083
Market Cap
11.31M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2020 | 12 | -44 | -78.57% |
Dec 31, 2014 | 56 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CSCI News
- 11 days ago - COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents - Newsfile Corp
- 17 days ago - COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization - GlobeNewsWire
- 4 months ago - COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs - GlobeNewsWire
- 6 months ago - COSCIENS Biopharma Announces Change to Board of Directors - GlobeNewsWire
- 6 months ago - COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director - GlobeNewsWire
- 6 months ago - COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs - GlobeNewsWire
- 7 months ago - COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire